IFNG and tuberculosis: As proposed in the work of Rosenthal et al. [114], the answer may be a customized therapy designed after testing the cytokine response of peripheral blood from patients upon challenge with a panel of representative autoantigenic peptides in a manner similar to the IFN-γ release assay (IGRA) for tuberculosis.